Skip to content
MedsAcross

Medicine

Provocholine Inhalation Solution kit

Available on requestPrescription onlyUS FDA

Provocholine Inhalation Solution kit is a prescription medicine containing Methacholine chloride inhalation solution, marketed by Methapharm, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store the supplied powder at 59°F to 86°F (15°C to 30°C). Store ready-to-use…

Key facts

Active ingredient (INN)
Methacholine chloride inhalation solution
Brand
Provocholine Inhalation Solution
Dosage form
Kit
Packs
6 package
Marketing authorisation holder
Methapharm
Manufacturer
Methapharm
Origin register
US FDA, United States
Storage
Store the supplied powder at 59°F to 86°F (15°C to 30°C). Store ready-to-use kits and single-dose vials between 15°C to 25°C (59°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 March 2022
Identifiers
DailyMed set ID e8983096-65e6-41f2-8b6f-bbf0a7227307NDC 64281-110Application NDA019193

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
6 package in 1 package / 6 carton in 1 package / 1 kit in 1 carton * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic * 1 vial, plastic in 1 kit / 3 mL in 1 vial, plastic64281-110-06Methapharm14 July 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Methacholine chloride inhalation solution is a prescription medicine indicated for the diagnosis of bronchial airway hyperreactivity in adults and pediatric patients five years of age and older who do not have clinically apparent asthma. MedsAcross supplies Methacholine chloride inhalation solution for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Methacholine chloride inhalation solution

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Provocholine Inhalation Solution kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.